News
Important Only
Other
Italy's Prysmian sells part of stake in YOFC to help fund acquisition of US group Channell
April 14 (Reuters) - Italy's Prysmian PRY.MI sold a 3.7% stake in Hong Kong-listed Yangtze Optical Fibre and Cable (YOFC) 601869.SS for around HK$350.2 million ($45.16 million) to support its $1.15 billion acquisition of U.S. group Channell, the cable maker said on Monday.The stake in "YOFC ...Reuters
Mon, Apr 14
Other
Momentus Signs Long-Term Agreement To Partner With Leading 3D Printing Technology Leader Velo3d
April 14 (Reuters) - Momentus Inc MNTS.O:MOMENTUS SIGNS LONG-TERM AGREEMENT TO PARTNER WITH LEADING 3D PRINTING TECHNOLOGY LEADER VELO3DMOMENTUS INC - ENTERS FIVE-YEAR MASTER SERVICES AGREEMENT WITH VELO3DReuters
Mon, Apr 14
Other
Intel Announces Strategic Investment By Silver Lake In Altera
April 14 (Reuters) - Intel Corp INTC.O:INTEL ANNOUNCES STRATEGIC INVESTMENT BY SILVER LAKE IN ALTERAINTEL: RAGHIB HUSSAIN APPOINTED CHIEF EXECUTIVE OFFICER OF ALTERA.INTEL - ENTERED INTO A DEFINITIVE AGREEMENT TO SELL 51% OF ITS ALTERA BUSINESS TO SILVER LAKEINTEL - TRANSACTION VALUES ALTERA AT $8.7...Reuters
Mon, Apr 14
Cryptocurrencies
Best Crypto Presales with Safe Haven Potential as Goldman Sachs Predicts $4,500 Gold Price
Cryptocurrencies backed by gold, such as Paxos Gold ($PAXG) and Tether Gold ($XAUT), have not only matched the growth of gold price but also outperformed the wider crypto market. The gold spot price has surged around 24% since the beginning of this year. In comparison, $PAXG has increased around 23%...NewsBTC
Mon, Apr 14
Other
Accord Biopharma Announces Completion Of Udenyca(Pegfilgrastim-Cbqv) Franchise Acquisition From Coherus Biosciences, Inc., Expanding U.S. Biosimilar Portfolio
April 14 (Reuters) - Coherus BioSciences Inc CHRS.O:ACCORD BIOPHARMA, INC. ANNOUNCES COMPLETION OF UDENYCA® (PEGFILGRASTIM-CBQV) FRANCHISE ACQUISITION FROM COHERUS BIOSCIENCES, INC., EXPANDING U.S. BIOSIMILAR PORTFOLIOReuters
Mon, Apr 14
Other
Aditxt Subsidiary Adimune Announces Positive Results From Mayo Clinic Pre-Clinical Studies To Support FDA And European Regulatory Submissions For Type 1 Diabetes, Psoriasis, And Stiff Person Syndrome Human Trials
April 14 (Reuters) - Aditxt Inc ADTX.O:ADITXT SUBSIDIARY ADIMUNE ANNOUNCES POSITIVE RESULTS FROM MAYO CLINIC PRE-CLINICAL STUDIES TO SUPPORT FDA AND EUROPEAN REGULATORY SUBMISSIONS FOR TYPE 1 DIABETES, PSORIASIS, AND STIFF PERSON SYNDROME HUMAN TRIALSReuters
Mon, Apr 14
Other
Aulos Bioscience Doses First Patient In Phase 2 Cohort Evaluating Au-007 In Combination With Nivolumab For Second-Line Treatment Of Melanoma
April 14 (Reuters) - AULOS BIOSCIENCE DOSES FIRST PATIENT IN PHASE 2 COHORT EVALUATING AU-007 IN COMBINATION WITH NIVOLUMAB FOR SECOND-LINE TREATMENT OF MELANOMAFurther company coverage: [ ]Reuters
Mon, Apr 14
Other
Certara Inc - Entered Into Amendment To Previously Disclosed Letter Agreement Between Co And Arsenal Saturn Holdings Lp
April 14 (Reuters) - Certara Inc CERT.O:CERTARA INC - ENTERED INTO AMENDMENT TO PREVIOUSLY DISCLOSED LETTER AGREEMENT BETWEEN CO AND ARSENAL SATURN HOLDINGS LPCERTARA INC - ARSENAL SATURN HOLDINGS PROHIBITED FROM TRANSFERRING CERTARA SHARES UNTIL APRIL 14, 2026 - SEC FILINGSource text: [ID:n0001827...Reuters
Mon, Apr 14
Other
Nextplat's Global Telesat Receives Connectivity Services Contract Extension From Military Customer
April 14 (Reuters) - NextPlat Corp NXPL.O:NEXTPLAT'S GLOBAL TELESAT RECEIVES CONNECTIVITY SERVICES CONTRACT EXTENSION FROM MILITARY CUSTOMERNEXTPLAT CORP - GLOBAL TELESAT RECEIVES ONE-YEAR CONTRACT EXTENSION FROM AFRICAN MILITARY CUSTOMERReuters
Mon, Apr 14
Other
Stem Inc -On April 9, Announces Workforce Reduction Plan - SEC Filing
April 14 (Reuters) - Stem Inc STEM.N:STEM INC -ON APRIL 9, ANNOUNCES WORKFORCE REDUCTION PLAN - SEC FILINGSTEM INC - PLAN TO REDUCE GLOBAL WORKFORCE BY APPROXIMATELY 27% - SEC FILINGSTEM INC - ESTIMATED CASH EXPENDITURES FOR PLAN $6.0 MILLION TO $6.5 MILLION - SEC FILINGSTEM INC: ESTIMATES PARTIAL Y...Reuters
Mon, Apr 14
